Key Takeaways Palantir shares fell 18% in a month, seen as a healthy correction and entry opportunity.Strong U.S. government and commercial contracts support PLTRs revenue visibility and growth.PLTR ended Q2 2025 with $6B cash, no debt and a record$1B+ quarterly revenue milestone.Palantir (PLTR) is seeing a healthy correction, with the stock dropping 18% over the past month. After soaring to all-time highs, some profit-taking was inevitable, especially given its rich valuations. This pullback does not seem ...